http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 13 Oct 2026 09:10:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bluejay+Diagnostics%2C++++++For%3A+Oct+13/27178624.html si-local-file:///var/storage/secattach/20261013/27178624.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bluejay+Diagnostics%2C++++++For%3A+Oct+13/27178624.html Tue, 13 Oct 2026 09:10:00 -0400 BJDX http://www.streetinsider.com/Corporate+News/Bluejay+Diagnostics+meets+Toray+manufacturing+deadline+early/27176590.html <p>Bluejay Diagnostics, Inc. (NASDAQ: BJDX) announced it has completed the establishment of a manufacturing site for its Symphony™ cartridges, fulfilling a contractual obligation under its amended license agreement with Toray Industries, Inc. ahead of the October 23, 2026 deadline.</p><p>The company has formally notified Toray that it has substantially completed the manufacturing site requirement. The manufacturing infrastructure relies on two facilities: SanyoSeiko Co., Ltd. in Japan, which serves as the site established under the Toray agreement, and ALURIS Sciences, formerly known as Argonaut Manufacturing Services, in the United States.</p><p>"Our manufacturing strategy is designed to extend beyond a single facility or geography," http://www.streetinsider.com/Corporate+News/Bluejay+Diagnostics+meets+Toray+manufacturing+deadline+early/27176590.html Tue, 13 Oct 2026 06:31:23 -0400 BJDX http://www.streetinsider.com/Press+Releases/Bluejay+Achieves+Toray+Contractual+Manufacturing+Milestone%2C+Advancing+Supply-Chain+Resilience+and+Commercialization+Readiness/27176557.html <p><strong id="dateline">ACTON, MA / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / October 13, 2026 / </strong>Bluejay Diagnostics, Inc. (NASDAQ:BJDX) ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes through its Symphony™ near-patient diagnostic platform, today announced that it has completed the establishment of a manufacturing site for Symphony™ cartridges, achieving a critical contractual milestone as the Company advances toward regulatory submission and potential commercialization.</p><a href="https://pr.report/s8cr" rel="nofollow"><img src="https://app.accessnewswire.com/imagelibrary/b10c21f0-4e82-42aa-9b66-81d3ea47d328/1235016/bjdx-logo-v2.png" style="text-align:center;margin:0.9em auto;" /></a><div style="clear: both"> </div><div> </div><div> </div><p>The milestone was achieved ahead of the October 23, 2026 contractual deadline established under Bluejay's amended license agreement with http://www.streetinsider.com/Press+Releases/Bluejay+Achieves+Toray+Contractual+Manufacturing+Milestone%2C+Advancing+Supply-Chain+Resilience+and+Commercialization+Readiness/27176557.html Tue, 13 Oct 2026 06:30:00 -0400 BJDX http://www.streetinsider.com/ACCESS+Newswire/Bluejay+Achieves+Toray+Contractual+Manufacturing+Milestone%2C+Advancing+Supply-Chain+Resilience+and+Commercialization+Readiness/27176557.html <p><strong id="dateline">ACTON, MA / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / October 13, 2026 / </strong>Bluejay Diagnostics, Inc. (NASDAQ:BJDX) ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes through its Symphony™ near-patient diagnostic platform, today announced that it has completed the establishment of a manufacturing site for Symphony™ cartridges, achieving a critical contractual milestone as the Company advances toward regulatory submission and potential commercialization.</p><a href="https://pr.report/s8cr" rel="nofollow"><img src="https://app.accessnewswire.com/imagelibrary/b10c21f0-4e82-42aa-9b66-81d3ea47d328/1235016/bjdx-logo-v2.png" style="text-align:center;margin:0.9em auto;" /></a><div style="clear: both"> </div><div> </div><div> </div><p>The milestone was achieved ahead of the October 23, 2026 contractual deadline established under Bluejay's amended license agreement with http://www.streetinsider.com/ACCESS+Newswire/Bluejay+Achieves+Toray+Contractual+Manufacturing+Milestone%2C+Advancing+Supply-Chain+Resilience+and+Commercialization+Readiness/27176557.html Tue, 13 Oct 2026 06:30:00 -0400 BJDX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bluejay+Diagnostics%2C++++++For%3A+Oct+06/27153147.html si-local-file:///var/storage/secattach/20261006/27153147.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bluejay+Diagnostics%2C++++++For%3A+Oct+06/27153147.html Tue, 06 Oct 2026 09:04:00 -0400 BJDX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+ZEIDMAN+FRED+S/26944495.html si-local-file:///var/storage/secattach/20260818/26944495.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+ZEIDMAN+FRED+S/26944495.html Tue, 18 Aug 2026 16:17:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+ZEIDMAN+FRED+S/26944495.html si-local-file:///var/storage/secattach/20260818/26944495.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+ZEIDMAN+FRED+S/26944495.html Tue, 18 Aug 2026 16:17:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+CHASE+DONALD+R/26944454.html si-local-file:///var/storage/secattach/20260818/26944454.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+CHASE+DONALD+R/26944454.html Tue, 18 Aug 2026 16:16:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+CHASE+DONALD+R/26944454.html si-local-file:///var/storage/secattach/20260818/26944454.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+CHASE+DONALD+R/26944454.html Tue, 18 Aug 2026 16:16:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Dey+Svetlana/26944466.html si-local-file:///var/storage/secattach/20260818/26944466.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Dey+Svetlana/26944466.html Tue, 18 Aug 2026 16:16:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Dey+Svetlana/26944466.html si-local-file:///var/storage/secattach/20260818/26944466.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Dey+Svetlana/26944466.html Tue, 18 Aug 2026 16:16:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Dey+Indranil/26944467.html si-local-file:///var/storage/secattach/20260818/26944467.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Dey+Indranil/26944467.html Tue, 18 Aug 2026 16:16:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Dey+Indranil/26944467.html si-local-file:///var/storage/secattach/20260818/26944467.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Dey+Indranil/26944467.html Tue, 18 Aug 2026 16:16:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Wurth+Douglas+Clark/26944487.html si-local-file:///var/storage/secattach/20260818/26944487.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Wurth+Douglas+Clark/26944487.html Tue, 18 Aug 2026 16:16:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Wurth+Douglas+Clark/26944487.html si-local-file:///var/storage/secattach/20260818/26944487.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+17++Filed+by%3A+Wurth+Douglas+Clark/26944487.html Tue, 18 Aug 2026 16:16:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Bluejay+Diagnostics%2C+++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26926104.html si-local-file:///var/storage/secattach/20260814/26926104.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Bluejay+Diagnostics%2C+++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26926104.html Fri, 14 Aug 2026 10:04:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Bluejay+Diagnostics%2C+++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26926104.html si-local-file:///var/storage/secattach/20260814/26926104.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Bluejay+Diagnostics%2C+++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26926104.html Fri, 14 Aug 2026 10:04:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Bluejay+Diagnostics%2C+++++++++++++++++++Filed+by%3A+Ayrton+Capital+LLC/26919086.html si-local-file:///var/storage/secattach/20260813/26919086.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Bluejay+Diagnostics%2C+++++++++++++++++++Filed+by%3A+Ayrton+Capital+LLC/26919086.html Thu, 13 Aug 2026 12:27:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Bluejay+Diagnostics%2C+++++++++++++++++++Filed+by%3A+Ayrton+Capital+LLC/26919086.html si-local-file:///var/storage/secattach/20260813/26919086.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Bluejay+Diagnostics%2C+++++++++++++++++++Filed+by%3A+Ayrton+Capital+LLC/26919086.html Thu, 13 Aug 2026 12:27:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+13/26916654.html si-local-file:///var/storage/secattach/20260813/26916654.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+13/26916654.html Thu, 13 Aug 2026 07:56:00 -0400 BJDX O.52744728 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+13/26916654.html si-local-file:///var/storage/secattach/20260813/26916654.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bluejay+Diagnostics%2C++++++For%3A+Aug+13/26916654.html Thu, 13 Aug 2026 07:56:00 -0400 BJDX O.52744728 http://www.streetinsider.com/Corporate+News/Bluejay+Diagnostics+completes+enrollment+in+IL-6+pivotal+study/26915424.html <p>Bluejay Diagnostics, Inc. (NASDAQ: BJDX) reported its second-quarter 2026 financial results, disclosing that its SYMON-II pivotal clinical study has completed targeted enrollment of 750 hospital patients, according to a press release from the Acton, Mass.-based company.</p><p>The company said it is progressing toward analytical and clinical validation activities intended to support a future FDA 510(k) submission for its Symphony IL-6 test, a rapid diagnostic tool for sepsis triage. Bluejay also signed a U.S. manufacturing contract, which the company said is intended to mitigate supply-chain risk ahead of a planned commercialization effort.</p><p>At June 30, 2026, Bluejay held approximately $9.6 million in cash http://www.streetinsider.com/Corporate+News/Bluejay+Diagnostics+completes+enrollment+in+IL-6+pivotal+study/26915424.html Thu, 13 Aug 2026 06:01:06 -0400 BJDX http://www.streetinsider.com/Press+Releases/Bluejay+Diagnostics+Reports+Q2+2026+Results%3B+Strengthened+Balance+Sheet+Supports+Advancement+of+Symphony%E2%84%A2+IL-6+Toward+Regulatory+Submission+and+Commercialization/26915406.html <ul type="disc"><li style="margin-bottom:8pt;"><strong><em>SYMON-II pivotal clinical study completes targeted enrollment of 750 patients</em></strong></li><li style="margin-bottom:8pt;"><strong><em>Company advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate supply-chain risk</em></strong></li><li style="margin-bottom:8pt;"><strong><em>Company ends second quarter with approximately $9.6 million in cash following significant financing</em></strong><br/><br/></li></ul> <p>ACTON, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on improving patient outcomes in critical care settings, today reported financial results for the quarter ended June 30, 2026 and provided an update on the Company’s clinical, regulatory and manufacturing progress.</p> <p>During http://www.streetinsider.com/Press+Releases/Bluejay+Diagnostics+Reports+Q2+2026+Results%3B+Strengthened+Balance+Sheet+Supports+Advancement+of+Symphony%E2%84%A2+IL-6+Toward+Regulatory+Submission+and+Commercialization/26915406.html Thu, 13 Aug 2026 06:00:00 -0400 BJDX O.52744728 http://www.streetinsider.com/Press+Releases/Bluejay+Diagnostics+Reports+Q2+2026+Results%3B+Strengthened+Balance+Sheet+Supports+Advancement+of+Symphony%E2%84%A2+IL-6+Toward+Regulatory+Submission+and+Commercialization/26915406.html <ul type="disc"><li style="margin-bottom:8pt;"><strong><em>SYMON-II pivotal clinical study completes targeted enrollment of 750 patients</em></strong></li><li style="margin-bottom:8pt;"><strong><em>Company advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate supply-chain risk</em></strong></li><li style="margin-bottom:8pt;"><strong><em>Company ends second quarter with approximately $9.6 million in cash following significant financing</em></strong><br/><br/></li></ul> <p>ACTON, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on improving patient outcomes in critical care settings, today reported financial results for the quarter ended June 30, 2026 and provided an update on the Company’s clinical, regulatory and manufacturing progress.</p> <p>During http://www.streetinsider.com/Press+Releases/Bluejay+Diagnostics+Reports+Q2+2026+Results%3B+Strengthened+Balance+Sheet+Supports+Advancement+of+Symphony%E2%84%A2+IL-6+Toward+Regulatory+Submission+and+Commercialization/26915406.html Thu, 13 Aug 2026 06:00:00 -0400 BJDX O.52744728 http://www.streetinsider.com/Globe+Newswire/Bluejay+Diagnostics+Reports+Q2+2026+Results%3B+Strengthened+Balance+Sheet+Supports+Advancement+of+Symphony%E2%84%A2+IL-6+Toward+Regulatory+Submission+and+Commercialization/26915406.html <ul type="disc"><li style="margin-bottom:8pt;"><strong><em>SYMON-II pivotal clinical study completes targeted enrollment of 750 patients</em></strong></li><li style="margin-bottom:8pt;"><strong><em>Company advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate supply-chain risk</em></strong></li><li style="margin-bottom:8pt;"><strong><em>Company ends second quarter with approximately $9.6 million in cash following significant financing</em></strong><br/><br/></li></ul> <p>ACTON, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on improving patient outcomes in critical care settings, today reported financial results for the quarter ended June 30, 2026 and provided an update on the Company’s clinical, regulatory and manufacturing progress.</p> <p>During http://www.streetinsider.com/Globe+Newswire/Bluejay+Diagnostics+Reports+Q2+2026+Results%3B+Strengthened+Balance+Sheet+Supports+Advancement+of+Symphony%E2%84%A2+IL-6+Toward+Regulatory+Submission+and+Commercialization/26915406.html Thu, 13 Aug 2026 06:00:00 -0400 BJDX O.52744728